Mechanism and Disease Association With a Ubiquitin Conjugating E2 Enzyme: UBE2L3.

Front Immunol

Key Laboratory of the Digestive System Tumors of Gansu Province, Lanzhou University Second Hospital, Lanzhou, China.

Published: May 2022

Ubiquitin conjugating enzyme E2 is an important component of the post-translational protein ubiquitination pathway, which mediates the transfer of activated ubiquitin to substrate proteins. UBE2L3, also called UBcH7, is one of many E2 ubiquitin conjugating enzymes that participate in the ubiquitination of many substrate proteins and regulate many signaling pathways, such as the NF-κB, GSK3β/p65, and DSB repair pathways. Studies on UBE2L3 have found that it has an abnormal expression in many diseases, mainly immune diseases, tumors and Parkinson's disease. It can also promote the occurrence and development of these diseases. Resultantly, UBE2L3 may become an important target for some diseases. Herein, we review the structure of UBE2L3, and its mechanism in diseases, as well as diseases related to UBE2L3 and discuss the related challenges.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899012PMC
http://dx.doi.org/10.3389/fimmu.2022.793610DOI Listing

Publication Analysis

Top Keywords

ubiquitin conjugating
12
conjugating enzyme
8
substrate proteins
8
ube2l3
6
diseases
6
mechanism disease
4
disease association
4
ubiquitin
4
association ubiquitin
4
enzyme ube2l3
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!